Menu
Not yet recruiting NCT07631975

ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK AMONG OLDER ADULTS RECEIVING INSTITUTIONAL CARE

Observational Older Adults (65 Years and Older) INSTITUTIONAL CARE Dual Task Cost Falls in Old Age

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Older Adults (65 Years and Older), INSTITUTIONAL CARE, Dual Task Cost, Falls in Old Age. Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK IN OLDER ADULTS RECEIVING INSTITUTIONAL CARE: A CROSS-SECTIONAL CLASSIFICATION MODEL

Overview

There is a need for studies that examine the role of dual-task cost in predicting fall risk among older adults receiving institutional care and that develop classification models that can be used in clinical practice. The planned study aims to determine the discriminative ability of dual-task cost in identifying fall risk and to establish clinically meaningful cutoff values. In this respect, the study will both contribute to a more sensitive assessment of fall risk and provide a scientific basis for a low-cost, practical, and applicable screening approach.

Detailed description

Changes in motor and cognitive functions that occur with the aging process negatively affect individuals' mobility and balance performance, there by increasing the risk of falls. Today, it is widely accepted that gait and postural control are not merely motor processes, but also require the active participation of attention and executive cognitive processes. In this context, the dual-task approach-wherein an individual simultaneously performs a second cognitive or motor task during gait-has become a widely utilized method for evaluating cognitive-motor interaction in older adults (Muir-Hunter \& Wittwer, 2016). Performance degradation under dual-task conditions is explained by the individual having to allocate limited cognitive resources between two tasks, a phenomenon that becomes particularly more pronounced in older adults. Studies in the literature examining the relationship between dual-task performance and falls demonstrate that performance changes occurring under dual-task conditions are more strongly associated with falls compared to single-task conditions (Muir-Hunter \& Wittwer, 2016). However, there is still no full consensus on which protocol, which secondary task, and which performance outcome are clinically most meaningful in dual-task assessments. The dual-task Timed Up and Go (TUG) test stands out as a practical and clinically applicable method for evaluating functional mobility. Tang et al. (2014) showed that motor dual-task TUG performance was superior to single-task TUG in discriminating the state of prefrailty in middle-aged and older adults. In the same study, it was reported that the ROC analysis of dual-task TUG performance showed significant discriminative power, and slow performance significantly increased the likelihood of prefrailty. These findings reveal that dual-task-based measurements are not only explanatory but also possess the potential to serve as classification tools and contribute to clinical decision-making processes. The relationship between cognitive functions and dual-task performance is another notable topic in the literature. It has been shown that both gait performance and cognitive performance deteriorate more markedly under dual-task conditions in individuals with mild cognitive impairment (Muir-Hunter \& Wittwer, 2016). Furthermore, it is indicated that the type and difficulty level of the secondary task used have significant effects on dual-task performance. This situation highlights the critical importance of standardizing dual-task assessments. Fear of falling is also a major factor affecting functional performance in older adults. In a study conducted by Sapmaz et al. (2021) on institutionalized older adults, it was shown that individuals with a fear of falling had worse single-task and dual-task TUG performances; additionally, their balance and mobility levels were also lower. These findings demonstrate that the fear of falling is not merely a psychological condition but is closely related to functional capacity. However, a large part of current studies remains at the group-comparison level, and analyses modeling the role of dual-task performance in predicting clinical fall risk remain limited. Recent studies show that dual-task assessments are highly sensitive in uncovering hidden functional impairments in older adults (Falbo et al., 2016). Especially in frail populations such as institutionalized older adults, dual-task performance is thought to be closely associated with falls. However, most of these studies either feature intervention-based designs or are limited strictly to correlation analyses. A prominent gap in the literature is the scarcity of studies evaluating fall risk via dual-task cost (which represents the relative change compared to single-task performance) rather than absolute measurements of dual-task performance. Because dual-task cost reflects the relative deterioration in an individual's performance under cognitive load, it may serve as a clinically more meaningful indicator. Nevertheless, studies examining the role of dual-task cost in discriminating fall risk and establishing a cross-sectional classification model based on this variable remain highly limited.

Primary outcome measures

  • Clinical Information Form [Time frame: Single assessment (baseline)]
  • Fall Assesment [Time frame: Single assessment (baseline)]
  • Montreal Cognitive Assessment (MoCA) [Time frame: Single assessment (baseline)]
  • Timed Up and Go Test (TUG) [Time frame: Single assessment (baseline)]
  • Dual-task Timed Up and Go Test (TUG-DT) [Time frame: Single assessment (baseline)]
  • Dual-Task Cost (DTC) [Time frame: Single assessment (baseline)]
  • Tinetti Performance-Oriented Mobility Assessment (POMA) [Time frame: Single assessment (baseline)]
  • Falls Efficacy Scale-International (FES-I) [Time frame: Single assessment (baseline)]

Eligibility criteria

Inclusion criteria

  • Being 65 years of age or older
  • Residing in a nursing home or care institution for at least 1 month
  • Ability to walk a distance of at least 10 meters
  • Ability to ambulate independently with an assistive device (e.g., cane, walker), if needed
  • Having a Montreal Cognitive Assessment (MoCA) score of 18 or above
  • Ability to understand and execute single- and two-step verbal commands
  • Voluntary agreement to participate in the study and providing informed consent

Exclusion criteria

  • History of stroke or major orthopedic surgery within the past 6 monthsPresence of Parkinson's disease Stage ≥3 (Hoehn \& Yahr) or any other neurological condition significantly affecting gait
  • Having a MoCA score below 18
  • History of fracture within the past 3 months
  • Presence of severe pain affecting gait during test administration (Visual Analog Scale \[VAS\] ≥ 7)
  • Uncontrolled hypertension (≥ 180/100 mmHg) or unstable cardiovascular status
  • Active vestibular disease or a history of syncope within the past 3 months
  • Visual or hearing impairment severe enough to impede test execution
  • Inability to walk/ambulate without the physical assistance of another person

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

Turkey (Türkiye) · 1 center
  • ONDOKUZ MAYIS UNIVERSITY, Samsun, Atakum 55270 — Samsun

Identifiers

NCT: NCT07631975 · 2026/276

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗